While scrolling through the posts here and trying to understand the implications of the recent results, and what they may, or may not have, meant I ended up reading an article on another site which discussed SRX and OS vs PFS, which I found very helpful. There were a couple of links within that article, one to the FDA and the other to the Journal Of Clinical Oncology which were also very informative... the link is do not advertise external blogs/2015/05/15/sirflox-os-v-pfs/ for anyone interested. I'm still very positive on SRX but it will be any sales increase/slowdown which will tell us how oncologists view the results.
SRX OS vs PFS
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $9.047K | 50.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7293686 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1399496 | 11 |
View Market Depth
| Last trade - 15.01pm 26/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |